Advertisement

Topics

Maiden Holdings, Ltd. to Release Second Quarter 2015 Earnings on August 4, 2015 and Host Conference Call on August 5, 2015

20:00 EDT 21 Jul 2015 | Globe Newswire

HAMILTON, Bermuda, July 22, 2015 (GLOBE NEWSWIRE) -- Maiden Holdings, Ltd. ("Maiden") (NASDAQ:MHLD) plans to release second quarter 2015 financial results following the market close on Tuesday, August 4, 2015. Art Raschbaum, Chief Executive Officer and Karen Schmitt, Chief Financial Officer will review these results via teleconference and live audio webcast on Wednesday, August 5, 2015 beginning at 8:30 a.m. ET.

To participate in the conference call, please access one of the following at least five minutes prior to the start time:

U.S. Callers: 1.877.734.5373

Outside U.S. Callers: 1.973.200.3059

Passcode: 91047354

Webcast: http://www.maiden.bm/news_events

A replay of the conference call will be available beginning at 11:30 a.m. ET on August 5, 2015 through midnight on August 19, 2015. To listen to the replay, please dial toll free: 1.855.859.2056 (U.S. Callers) or toll: 1.404.537.3406 (callers outside the U.S.) and enter the Passcode: 91047354; or access http://www.maiden.bm/news_events

About Maiden Holdings, Ltd.

Maiden Holdings, Ltd. is a Bermuda-based holding company formed in 2007. Through its subsidiaries, which are each A- rated (excellent) by A.M. Best, the Company is focused on providing non-catastrophic, customized reinsurance products and services to small and mid-size insurance companies in the United States and Europe. As of March 31, 2015, Maiden had $5.5 billion in assets and shareholders' equity of $1.3 billion.

The Maiden Holdings, Ltd. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5006

CONTACT: Noah Fields, Vice President, Investor Relations
         Maiden Holdings, Ltd.
         Phone: 441.298.4927
         E-mail: nfields@maiden.bm

company logo

NEXT ARTICLE

More From BioPortfolio on "Maiden Holdings, Ltd. to Release Second Quarter 2015 Earnings on August 4, 2015 and Host Conference Call on August 5, 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...